Login

Financial Snapshot

Revenue
TTM
$56.72M
Gross Margin
TTM
11.8%
Net Income
TTM
-$10.58M
Current Assets
2025 Q1
$42.94M
Current Liabilities
2025 Q1
$23.59M
Current Ratio
2025 Q1
182.07%
Total Assets
2025 Q1
$207.4M
Total Liabilities
2025 Q1
$25.27M
Book Value
2025 Q1
182.1M
Cash
Last 4 Quarters
N/A
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$4.040M

Stock Price

Loading...
Market Cap: $53.287 Million

About BGM Group Ltd

BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. The company is headquartered in Chengdu, Sichuan and currently employs 323 full-time employees. The company went IPO on 2021-01-12. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The firm's main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.

Industry: Pharmaceutical Preparations Peers: China Pharma Holdings Inc China SXT Pharmaceuticals Inc SUNWIN STEVIA INTERNATIONAL, INC. Universe Pharmaceuticals Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support